JARDY MET 12.5MG 1000MG TAB 14s

Jardy Met 12.5/1000mg Tablets – Dual Action Diabetes Control (14’s)
Meta Description: Jardy Met combines Empagliflozin 12.5mg and Metformin 1000mg to effectively manage type 2 diabetes, improve blood sugar control, and reduce diabetes-related risks.

Description:
Jardy Met is a combination of Empagliflozin (SGLT2 inhibitor) and Metformin (biguanide) designed for effective management of type 2 diabetes. It lowers blood sugar, reduces glucose reabsorption in the kidneys, and improves insulin sensitivity.

Uses:

• Management of type 2 diabetes mellitus.

• Helps reduce risk of cardiovascular complications in diabetic patients.

• Supports weight and blood pressure control.

Benefits:

• Dual action for superior blood sugar control.

• Helps reduce HbA1c levels.

• May aid in weight management and heart protection.

Side Effects:

• Urinary tract infections, frequent urination.

• Nausea, diarrhea, or stomach upset.

• Rare: dehydration, ketoacidosis, lactic acidosis.